That's a weight-loss drug demonstrating outcomes beyond the scale, in one of the highest-risk populations in medicine
Retatrutide has not been compared head-to-head with earlier GLP-1 medications in any clinical trials, although there is an ongoing trial called TRIUMPH-5, which is comparing it with tirzepatide
Any use of the Website not expressly permitted by this Agreement is a breach of this Agreement and may violate copyright, trademark, and other laws
These gradually thicken and darken to match the rest of your hair over subsequent months
However, a number of challenges will need to be addressed over next years including a better understanding of the full potential of benefits and risks with the new obesity pharmacotherapies and ensuring wide and equal access for people living with obesity
Safety Considerations and Clinical Eligibility GLP-1 medications, as described in SkinnyRx's published patient protocols, are intended for adults aged 18 and older